The overall survival (OS) of BC patients in the high GPX1 expression group was longer than those in the low GPX1 expression group (hazard ratio [HR] = 0.89, 95% CI 0.79–1.00, p = 0.0469) (Figure 4B), indicating a prognostic value of GPX1. Here, GPX1 is linked to breast cancer.